Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/31/09
End: 06/30/11
Due: 06/30/12
Phase: N/A
Priority: Normal
Start: 12/31/08
End: 06/30/09
Due: 06/30/10
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Active Control, Double-blind, Double-dummy, Parallel-group, Randomized Study to Assess the Effect of VECAM 40/300, Administered at Bedtime, vs. Esomeprazole 20 mg, Administered 30-60 Min. Before Dinner, on Daytime and Nighttime GERD Symptoms | NCT01059383 | Vecta Ltd. | user2@example.com | None | 2009-12-31 | 2011-06-30 | 2012-06-30 | - | - | 2025-07-14 |
| Effect of Vecam 40/300 and Vecam 20/300 Compared to Omeprazole 20 mg on Gastric pH | NCT00818870 | Vecta Ltd. | user2@example.com | None | 2008-12-31 | 2009-06-30 | 2010-06-30 | - | - | 2025-07-14 |